Improving gene therapy for Krabbe Disease
Improving AAV-based gene therapy for Krabbe Disease
This study is looking at a new way to improve gene therapy for Krabbe Disease by using a virus to deliver a healthy copy of a missing gene, and it's aimed at helping people with this condition feel better in the future.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10887523 on NIH RePORTER |
What this research studies
This research focuses on enhancing adeno-associated virus (AAV) gene therapy for Krabbe Disease, a severe genetic disorder that affects the nervous system. The approach involves using AAV vectors to deliver a functional copy of the GALC gene, which is deficient in patients with this condition. By studying the effectiveness of this therapy in animal models, the researchers aim to understand how to maintain its efficacy over time and potentially translate these findings into clinical applications for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and young children diagnosed with Krabbe Disease, particularly those under the age of three.
Not a fit: Patients with advanced Krabbe Disease or those who have already undergone other treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective gene therapy for Krabbe Disease, improving the quality of life and extending survival for patients.
How similar studies have performed: Previous research has shown promising results with AAV gene therapy in other genetic disorders, indicating potential for success in Krabbe Disease as well.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Heller, Gregory J — University of Illinois at Chicago
- Study coordinator: Heller, Gregory J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.